Association Between Left Ventricular Diastolic Dysfunction and Chronic Obstructive Pulmonary Disease Severity: A Cross-Sectional Study
Keywords:
LVDD, Acute Exacerbation of Chronic Obstructive Pulmonary Disease, GOLD, FVC, ECGAbstract
Background: Chronic obstructive pulmonary disease (COPD) is frequently accompanied by cardiovascular comorbidities, notably left ventricular diastolic dysfunction (LVDD). Due to overlapping symptoms between LVDD and COPD-related dyspnea, cardiac involvement may go undetected. The association between COPD severity and LVDD has not been fully elucidated. Objective: To determine the prevalence of LVDD and assess its association with the severity of COPD in affected patients. Methodology: This cross-sectional analytical study was conducted in Peshawar, from September 2024 to August 2025. A total of 394 clinically stable COPD patients were consecutively recruited. COPD diagnosis was confirmed using post-bronchodilator spirometry in accordance with GOLD criteria. Transthoracic echocardiography assessed left ventricular systolic and diastolic function, regional contractility, and right ventricular systolic pressure. Results: The mean age of participants was 61.4 ± 8.2 years, with 84.5% being male. LVDD was identified in 246 patients (62.4%). Among those with LVDD, 189 (76.8%) exhibited grade 1 and 57 (23.2%) exhibited grade 2 dysfunction; no cases of grade 3 or 4 dysfunction were observed. LVDD was present in 55.8% of GOLD 2, 68.4% of GOLD 3, and 63.2% of GOLD 4 patients. There was no significant association between GOLD severity and LVDD (p=0.208). Older age was significantly associated with LVDD (p=0.002). FVC was significantly lower among patients with segmental contractility abnormalities (p=0.002), but was not associated with LVDD. Conclusion: LVDD was prevalent among patients with COPD, primarily as mild dysfunction, but was not significantly associated with spirometric measures of COPD severity. Age demonstrated a significant association with LVDD, underscoring the importance of cardiovascular assessment in this population.References
Balbirsingh V, Mohammed AS, Turner AM, Newnham M. Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review. Thorax. 2022;77(10):939-946. DOI:10.1136/thoraxjnl-2021-218333.
Maeda T, Dransfield MT. Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice. Curr Opin Pulm Med. 2024;30(2):141-149. DOI:10.1097/MCP.0000000000001040.
Ragnoli B, Chiazza F, Tarsi G, Malerba M. Biological pathways and mechanisms linking COPD and cardiovascular disease. Ther Adv Chronic Dis. 2025;16:20406223251314286. DOI:10.1177/20406223251314286.
Polman R, Hurst JR, Uysal OF, Mandal S, Linz D, Simons S. Cardiovascular disease and risk in COPD: a state of the art review. Expert Rev Cardiovasc Ther. 2024;22(4-5):177-191. DOI:10.1080/14779072.2024.2333786.
Sá-Sousa A, Rodrigues C, Jácome C, Cardoso J, Fortuna I, Guimarães M, et al. Cardiovascular risk in patients with chronic obstructive pulmonary disease: a systematic review. J Clin Med. 2024;13(17):5173. DOI:10.3390/jcm13175173.
Cherneva Z, Valev D, Youroukova V, Cherneva R. Left ventricular diastolic dysfunction in non-severe chronic obstructive pulmonary disease – a step forward in cardiovascular comorbidome. PLoS One. 2021;16(3):e0247940. DOI:10.1371/journal.pone.0247940.
Mupparapu M, Venkataram R, Baikunje N, D'Sa I, Thimmaiah CM. Assessment of left ventricular function in subjects with chronic obstructive pulmonary disease. Monaldi Arch Chest Dis. 2024;94(4). DOI:10.4081/monaldi.2023.2654.
Abdo M, Watz H, Alter P, Kahnert K, Trudzinski F, Groth EE, et al. Characterization and mortality risk of impaired left ventricular filling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2025;211(3):477-85. DOI:10.1164/rccm.202310-1848OC.
Caram LM, Ferrari R, Naves CR, Tanni SE, Coelho LS, Zanati SG, et al. Association between left ventricular diastolic dysfunction and severity of chronic obstructive pulmonary disease. Clinics. 2013 ;68(6):772-6.DOI: 10.4103/ecdt.ecdt_30_25.
Lookzadeh S, Seyyedi SR, Jamaati H, Miraboutalebi F, Rekabi M. Relationship between Severity of Chronic Obstructive Pulmonary Disease and Left Ventricular Diastolic Dysfunction. Tanaffos. 2024;23(3):294-99. PMID: 40704342.
Duus LS, Vesterlev D, Nielsen AB, Lassen MH, Sivapalan P, Ulrik CS, Lapperre T, et al. COPD: pulmonary vascular volume associated with cardiac structure and function. Int J Cardiovasc Imaging. 2024;40(3):579-89. DOI:10.1007/s10554-023-03027-1.
Nagueh SF, Sanborn DY, Oh JK, Anderson B, Billick K, Derumeaux G, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography and for heart failure with preserved ejection fraction diagnosis: an update from the American Society of Echocardiography. J Am Soc Echocardiogr. 2025;38(7):537-69. DOI:10.1016/j.echo.2025.03.011.
Polman R, Hurst JR, Uysal OF, Mandal S, Linz D, Simons S. Cardiovascular disease and risk in COPD: a state of the art review. Expert Rev Cardiovasc Ther. 2024;22(4-5):177-91. DOI:10.1080/14779072.2024.2333786.
Dos Santos NC, Miravitlles M, Camelier AA, De Almeida VD, Maciel RR, Camelier FW. Prevalence and impact of comorbidities in individuals with chronic obstructive pulmonary disease: a systematic review. Tuberc Respir Dis. 2022;85(3):205. DOI:10.4046/trd.2021.0179.
Löffler F, Westhoff?Bleck M, Welte T, Park DH, Olsson KM, Behrendt L, et al. Doppler?derived pulmonary pulse transit time measurements in chronic obstructive pulmonary disease: Reproducibility and cardiopulmonary function. Echocardiogr. 2024;41(5):e15821. DOI:10.1111/echo.15821.
Meng K, Zhang X, Dai H. Obstructive airway disease is associated with increased cardiovascular disease risk independent of phenotype: Evidence from two nationwide population-based studies. Int J Chron Obstruct Pulmon Dis. 2025:1435-46. DOI:10.2147/COPD.S522367.
Becher PM, Lindberg F, Benson L, Hage C, Dahlström U, Rosenkranz S, et al. Phenotyping patients with chronic obstructive pulmonary disease and heart failure. ESC Heart Fail. 2025;12(2):900-911. DOI:10.1002/ehf2.15127.
Polman R, Hurst JR, Uysal OF, Mandal S, Linz D, Simons S. Cardiovascular disease and risk in COPD: a state of the art review. Expert Rev Cardiovasc Ther. 2024;22(4-5):177-191. DOI:10.1080/14779072.2024.2333786.
Axson EL, Ragutheeswaran K, Sundaram V, Bloom CI, Bottle A, Cowie MR, et al. Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis. Respir Res. 2020;21:54. DOI:10.1186/s12931-020-1312-7.
Kibbler J, Wade C, Mussell G, Ripley DP, Bourke SC, Steer J. Systematic review and meta-analysis of prevalence of undiagnosed major cardiac comorbidities in COPD. ERJ Open Res. 2023;9(6):00548-2023. DOI:10.1183/23120541.00548-2023.
Robinson S, Ring L, Oxborough D, Harkness A, Bennett S, Rana B, et al. The assessment of left ventricular diastolic function: guidance and recommendations from the British Society of Echocardiography. Echo Res Pract. 2024;11(1):16. DOI:10.1186/s44156-024-00051-2.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Pakistan Journal of Chest Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.




